title: [Health economics evaluations are of great significance for Pharmaceutical Benefit Board's decisions].
authors.affiliation: Institutet för hälso- och sjukvårdsekonomi (IHE), Lund. up@ihe.se
authors.forename: Ulf
authors.initials: U
authors.lastname: Persson
authors.forename: Joakim
authors.initials: J
authors.lastname: Ramsberg
mesh_terms: D002017:Budgets; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics; D016568:Drugs, Generic / Q000191:economics; D004470:Economics, Medical; D017408:Guidelines as Topic; D006801:Humans; D010606:Pharmacy and Therapeutics Committee; D012051:Reimbursement Mechanisms; D013548:Sweden
chemical_list: D016568:Drugs, Generic